🔗 Permalink

Assignee profile:

AbbVie B.V.

City:

Hoofddorp

Country:

Netherlands

Published Applications:

Last publication date:

2019-07-18

Patent Grants:

Last grant date:

2020-10-20

Top Inventors for applications by AbbVie B.V.

These are the the leading inventors for applications assigned to AbbVie B.V.:

Wouter I. Iwema Bakker 8 Hoofddorp, Netherlands
Maria J. P. van Dongen 5 Hoofddorp, Netherlands
Hein K. A. C. Coolen 5 Hoofddorp, Netherlands
Adrian Hobson 5 Worcester, MA United States

Hein K.A.C. Coolen 5 Hoofddorp, Netherlands
Maria J.P. van Dongen 5 Hoofddorp, Netherlands
Jacobus A. J. den Hartog 3 Hoofddorp, Netherlands
Leonardus A.J.M. Sliedregt 3 Hoofddorp, Netherlands

Pieter Smid 3 Hoofddorp, Netherlands
Raymond Bronger 3 Hoofddorp, Netherlands
Leonardus A. J. M. Sliedregt 3 Hoofddorp, Netherlands
Jacobus A.J. den Hartog 3 Hoofddorp, Netherlands

Hein K.A.C. Coolen 2 Weesp, Netherlands
Hein K. A. C. Coolen 2 Weesp, Netherlands
Axel Stoit 2 Weesp, Netherlands
Cornelis G. Kruse 2 Weesp, Netherlands

Jan H. Reinders 2 Weesp, Netherlands
Axel Stoit 2 Hoofddorp, Netherlands
Nicolas J.-L.D. Leflemme 2 Hoofddorp, Netherlands
Nicolas J.-L. D. Leflemme 2 Hoofddorp, Netherlands

Bernard J. VAN VLIET 1 Weesp, Netherlands
Herman H. Van Stuivenberg 1 Weesp, Netherlands
Josephus H.M. Lange 1 Weesp, Netherlands
Josephus H. M. Lange 1 Weesp, Netherlands

Louise Terwel 1 Weesp, Netherlands

Recent patent applications by AbbVie B.V.

AbbVie B.V. based in Hoofddorp, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-07-18 ✅ Patent 10,807,991 granted on 2020-10-20

US20190218227A1

Chemistry; metallurgy

Spiro-cyclic amine derivatives as S1P modulators

#2 | 2016-06-02 ✅ Patent 9,662,337 granted on 2017-05-30

US20160151376A1

Human necessities

Bisaryl (thio)morpholine derivatives as S1P modulators

#3 | 2015-10-08 ✅ Patent 9,670,220 granted on 2017-06-06

US20150284403A1

Chemistry; metallurgy

Fused heterocyclic derivatives as S1P modulators

#4 | 2015-07-09 ✅ Patent 9,227,960 granted on 2016-01-05

US20150191457A1

Chemistry; metallurgy

Bisaryl (thio)morpholine derivatives as S1P modulators

#5 | 2014-03-20 ✅ Patent 8,735,388 granted on 2014-05-27

US20140080861A1

Chemistry; metallurgy

Heterocyclic compounds with affinity to muscarinic receptors

#6 | 2014-03-06 ✅ Patent 9,096,612 granted on 2015-08-04

US20140066433A1

Chemistry; metallurgy

Fused heterocyclic derivatives as S1P modulators

#7 | 2013-08-08 ✅ Patent 9,029,371 granted on 2015-05-12

US20130203745A1

Chemistry; metallurgy

Bisaryl (thio)morpholine derivatives as S1P modulators

#8 | 2013-08-08 ✅ Patent 8,796,262 granted on 2014-08-05

US20130203737A1

Chemistry; metallurgy

Fused heterocyclic derivatives as S1P modulators

#9 | 2013-08-01 ✅ Patent 10,179,791 granted on 2019-01-15

US20130196998A1

Chemistry; metallurgy

Spiro-cyclic amine derivatives as S1P modulators

#10 | 2012-04-19 ✅ Patent 8,586,606 granted on 2013-11-19

US20120095039A1

Chemistry; metallurgy

Heterocyclic compounds with affinity to muscarinic receptors

#11 | 2006-08-31 ✅ Patent 8,937,184 granted on 2015-01-20

US20060194779A1

Chemistry; metallurgy

1H-imidazole derivatives as cannabinoid CB2 receptor modulators

Also check out Abbvie B.V.'s (Hoofddorp, Netherlands) applicant profile with 6 patent applications submitted.

AssigneeID:

32818 ⎘